(8alpha)-5'alpha-benzyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione
![]() |
- $501.81
- Product name: (8alpha)-5'alpha-benzyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione
- CAS: 511-07-9
- MF: C35H39N5O5
- MW: 609.71
- EINECS:208-119-1
- MDL Number:MFCD22419190
- Synonyms:(8alpha)-5'alpha-benzyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione ;(8α)-12'-Hydroxy-2'-isopropyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione;Einecs 208-119-1;Ergotaman-3',6',18-trione, 12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,8alpha)-;Isoergocristine;(5'alpha,8alpha)-12'-Hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)ergotaman-3',6',18-trione;Ergocristinine;8a-isomer
1 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
Package
- 5MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0311067
- Product description8-ALPHA-ERGOCRISTINE ISOMER 95.00%
- Packaging5MG
- Price$501.81
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0311067 | 8-ALPHA-ERGOCRISTINE ISOMER 95.00% | 5MG | $501.81 | 2021-12-16 | Buy |
Properties
Melting point :226℃ (decomposition) (ethanol )
alpha :D20 +366° (c = 0.68 in chloroform); +471° (c = 0.35 in pyridine)
Boiling point :655.69°C (rough estimate)
Density :1.1839 (rough estimate)
refractive index :1.7210 (estimate)
pka :9.59±0.60(Predicted)
alpha :D20 +366° (c = 0.68 in chloroform); +471° (c = 0.35 in pyridine)
Boiling point :655.69°C (rough estimate)
Density :1.1839 (rough estimate)
refractive index :1.7210 (estimate)
pka :9.59±0.60(Predicted)
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|